Alaa received his B.Sc. in Biomedical Engineering from the Technion – Israel Institute of Technology in 2010. Alaa joined Prof. Haick’s group in 2011 as a R&D Engineer, which include software and hardware developments and building new measurement systems. In 2014 Alaa started his master studies under the supervision of Prof. Haick in a multidisciplinary research which combines nanotechnology, biomedical engineering and oncology to integrate common analytical methods and sensing technology for lung cancer genetic profiling through volatolomic signature. More specifically Alaa investigates the use of chemiresistors based on gold nanoparticles (Au NPs) and single wall carbon nanotubes (SWCNTs) for the cultivation of volatolomic signature associated with different cell compartments within lung cancer cell and detect specific volatile organic compounds (VOCs) associated with lung cancer development which are emitted from different organelles inside the cell.